NGNE

Neurogene Inc. $26.61 as of 2026-11-02
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.5%
Next 1 week
-1.2%
Next 1 month
+3.5%
Seasonality
Weak window historically
Next 30 days (to Dec 3): -6.7% median, 36% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 24
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.43%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.58 +3.7% · Seasonal tilt (11y) -0.2%
$9M/day volume 79% volatility -20% 1-year
52-week range · 39% of the way up · -39% from the high
$15.93$43.66

Earnings Full history →

Next report 2026-11-12 (Thursday, before open, in 9 days) · EPS est. -1.45.

1-day std dev
6.8%
Finished up
33%
Biggest pop
+5.4%
Biggest drop
-14.0%

Standard deviation of the close-to-close move over the last 9 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-11 miss -1.37 -1.53 -11.7% +2.2% +3.3% +10.1%
2026-03-24 beat -1.24 -1.13 +8.7% +1.6% +5.4% +3.6%
2025-11-13 beat -1.09 -0.99 +9.2% +1.7% -14.0% -24.3%
2025-08-11 beat -1.16 -1.05 +9.5% -1.9% -5.6% -3.1%
2025-05-09 miss -0.92 -1.08 -17.4% -2.3% -1.8% +19.9%
2025-03-24 beat -1.13 -0.99 +12.3% +1.5% +1.7% -30.8%
2024-11-18 beat -1.22 -1.19 +2.6% +5.4% -13.1% +35.6%
2024-08-09 miss -1.03 -1.09 -5.6% -1.0% -2.6% -4.2%
2024-05-10 miss -0.95 -1.00 -5.5% -1.3% -5.7% +4.6%

Not investment advice.